Timothy Scannell, President & COO at Stryker, holds 30.59K shares in Insulet (Ticker: PODD), holds 7.98K shares in NovoCure (Ticker: NVCR), holds 5.69K shares in Exact Sciences (Ticker: EXAS). Most recently, Timothy Scannell Sold ― shares of Insulet on Sep 11, 2024 for an estimated value of 1.13M.
Timothy Scannell latest transaction was an Informative Sell of $1.13M.
What was Timothy Scannell's most profitable transaction?
Timothy Scannell’s most profitable transaction was an Informative Sell of NVCR stock on June 6, 2024. The return on the trade was 26.90%.
What is Timothy Scannell's role in Stryker?
Timothy Scannell's role in Stryker is President & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.